Skip to main content
RDGL
OTC Life Sciences

FDA Approves Vivos Inc.'s RadioGel® for First-in-Human Cancer Study

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Industrial
Sentiment info
Positive
Importance info
9
Price
$0.057
Mkt Cap
$28.268M
52W Low
$0.043
52W High
$0.155
52W Position info
35% above low
Off High info
63% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

RDGL sits 35% above its 52-week low of $0.043.

Summary

Vivos Inc. has received FDA approval for an Investigational Device Exemption (IDE) for its RadioGel® product, enabling the start of a first-in-human clinical feasibility study in the U.S. for non-resectable papillary thyroid carcinoma. This significant regulatory milestone allows the company to advance its yttrium-90-based injectable hydrogel into human trials, with the initial study enrolling five patients at Mayo Clinic. This positive development follows the company's recent Q1 report, which detailed a widened net loss and ongoing financial challenges, providing a crucial validation of its core technology. The approval is a major de-risking event for the company's lead product and is essential for its long-term commercialization prospects.

At the time of this announcement, RDGL was trading at $0.06 on OTC in the Life Sciences sector, with a market capitalization of approximately $28.3M. The 52-week trading range was $0.04 to $0.15. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

RDGL - Latest Insights

RDGL
Nov 05, 2026, 8:54 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.042
Real-time Price: $0.042175 info
Change: +$0.000175 (+0.42%) info
Market Cap: $20.843M info
RDGL
Oct 08, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.045885
Real-time Price: $0.042175 info
Change: -$0.00371 (-8%) info
Market Cap: $20.843M info
RDGL
Oct 05, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0431
Real-time Price: $0.042175 info
Change: -$0.000925 (-2%) info
Market Cap: $20.843M info
RDGL
Oct 01, 2026, 5:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.04981
Real-time Price: $0.042175 info
Change: -$0.007635 (-15%) info
Market Cap: $20.843M info
RDGL
Aug 18, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.05735
Real-time Price: $0.042175 info
Change: -$0.015175 (-26%) info
Market Cap: $20.843M info